CLASS III Drug recall · Reported 20 May 2015 · FDA Enforcement Report

Monistat 1 Simple Cure (Miconazole Nitrate Vaginal Insert) recalled

Medtech Products is recalling Monistat 1 Simple Cure (Miconazole Nitrate Vaginal Insert) 1200 mg ovule, 1-Day Maximum, distributed nationwide in the US. The recall was initiated on 10 Apr 2015 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot#: R18193, Exp 10/2016
NDC63736-013
Quantity recalled4,175 cases (50,100 ovules); and 6 cases (72 ovules) as company samples

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1077-2015
FDA event ID
70932
Recalling firm
Medtech Products, Tarrytown, NY
Manufacturer
Insight Pharmaceuticals LLC
Classification
Class III
Status
Terminated
Recall initiated
10 Apr 2015
FDA classified
13 May 2015
Reported
20 May 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

10 Apr 2015Recall initiated by company
13 May 2015Classified by FDA+33 days
20 May 2015Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Marketed without an approved NDA/ANDA: The distributed units of Monistat 1 Simple Cure include only the 1200 mg vaginal suppository; the approved NDA requires both a 1200 mg vaginal suppository and the 2% topical cream.

Product as listed by the FDA

MONISTAT 1 SIMPLE CURE (Miconazole Nitrate Vaginal Insert) 1200 mg ovule, 1-DAY MAXIMUM STRENGTH TREATMENT OVULE per case, over-the-counter, Distributed by INSIGHT Pharmaceuticals, LLC, Trevose, PA 19053-8433, NDC 63736-013-30

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Marketed without an approved NDA/ANDA: The distributed units of Monistat 1 Simple Cure include only the 1200 mg vaginal suppository; the approved NDA requires both a 1200 mg vaginal suppository and the 2% topical cream.

Which lots are affected?

Lot#: R18193, Exp 10/2016

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medtech Products

All 18

Other Miconazole recalls

All 4